Fig. 3.
Improvement of peripheral red blood cell morphology in treated β-thalassemic mice.
May-Grünwald Giemsa staining of blood smears from an untreated heterozygous mouse, from an untreated β-thalassemic mouse, and from the β-thalassemic mouse No. 1 twelve months after intramuscular injection of the rAAV-CMV-Epo vector.